SPEAR UltraDetect

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of a hydropower dam, power infrastructure and site engineers, illustrating NHPC Limited’s OFS and India’s clean energy PSU investment story.

NHPC starts fifth Subansiri Lower unit, taking operational capacity to 1.250 GW as cost scrutiny grows

Northrop Grumman (NYSE: NOC) backlog hits $110bn as 2027 growth test begins

Representative image of offshore energy infrastructure and LNG processing facilities, highlighting Woodside Energy Group Ltd’s Q1 2026 focus on Scarborough execution, stronger realised pricing, and long-term WDS growth catalysts.

Woodside Energy (ASX: WDS) reaches 99% at Scarborough LNG as Q3 revenue climbs to $4.28bn

Roche (SIX: ROP) sales rise 7% as pipeline hopes meet a near-record valuation

Spear Bio unveils SPEAR UltraDetect, a new ultrasensitive immunoassay platform targeting neurology biomarkers

Spear Bio launches SPEAR UltraDetect, an ultrasensitive immunoassay platform enabling precise neurology biomarker detection in blood; Bio-Techne to distribute globally.

μFR system
αvβ6-integrin
α4β7 integrin
Þorgerður Katrín Gunnarsdóttir
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF

July 25, 2025